Takeda’s post-transplant CMV drug Livtencity, shouldering $800M in sales expectations, scores FDA nod
Takeda’s post-transplant CMV drug Livtencity, shouldering $800M in sales expectations, [...]
Takeda’s post-transplant CMV drug Livtencity, shouldering $800M in sales expectations, [...]
After Biden admin failed to submit FDA chief paperwork on [...]
FDA, working to tackle pandemic inspection backlog, struggles with foreign [...]
Sanofi coughs up $180M to settle Pompe disease royalty payment [...]
AstraZeneca CEO questions mRNA vaccine superiority, raising theory that his [...]
Novartis may have a buyer for $21B generics unit Sandoz: [...]
Sagent Pharmaceuticals recalls injectable seizure med thanks to familiar packaging [...]
EsoCap swallows up VC cash to fuel study of topical [...]
Amgen, Biohaven, Lilly and Teva plowed plenty into marketing migraine [...]
CDC vaccine advisers endorse Pfizer, Moderna COVID boosters for all [...]